Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Medical Informatics

Date Submitted: Jul 15, 2024
Date Accepted: Dec 25, 2024

The final, peer-reviewed published version of this preprint can be found here:

The Role of AI in Cardiovascular Event Monitoring and Early Detection: Scoping Literature Review

Elvas LB, Almeida A, Ferreira JC

The Role of AI in Cardiovascular Event Monitoring and Early Detection: Scoping Literature Review

JMIR Med Inform 2025;13:e64349

DOI: 10.2196/64349

PMID: 40048151

PMCID: 11905924

The Role of AI in Cardiovascular Event Monitoring and Early Detection: A Scoping Literature Review

  • Luis B. Elvas; 
  • Ana Almeida; 
  • Joao C Ferreira

ABSTRACT

Background:

Artificial Intelligence (AI) has shown exponential growth and advancements, revolutionizing various fields, including healthcare. However, domain adaptation remains a significant challenge, as machine learning (ML) models often need to be applied across different healthcare settings with varying patient demographics and practices. This issue is critical for ensuring effective and equitable AI deployment. Cardiovascular diseases (CVD), the leading cause of global mortality with 17.9 million annual deaths, encompass conditions like coronary heart disease and hypertension. The increasing availability of medical data, coupled with AI advancements, offers new opportunities for early detection and intervention in cardiovascular events, leveraging AI's capacity to analyse complex datasets and uncover critical patterns.

Objective:

This review aims to examine AI methodologies combined with medical data to advance the intelligent monitoring and detection of cardiovascular diseases, identifying areas for further research to enhance patient outcomes and support early interventions.

Methods:

This review follows the Preferred Reporting Items for Systematic Reviews and Meta-Analyses methodology to ensure a rigorous and transparent literature review process. This structured approach facilitated a comprehensive overview of the current state of research in this field.

Results:

Through the methodology utilized, there were retrieved 64 documents, 40 of which met the inclusion criteria. The reviewed articles demonstrate advancements in AI and ML for CVD detection, classification, prediction, diagnosis, and patient monitoring. Techniques such as ensemble learning, deep neural networks, and feature selection improve prediction accuracy over traditional methods. ML models predict cardiovascular events and risks, with applications in monitoring via wearable technology. The integration of AI in healthcare supports early detection, personalized treatment, and risk assessment, possibly improving the management of CVD.

Conclusions:

The study concludes that AI and ML techniques can improve the accuracy of cardiovascular disease classification, prediction, diagnosis, and monitoring. The integration of multiple data sources and non-invasive methods supports continuous monitoring and early detection. These advancements help enhance CVD management and patient outcomes, indicating the potential for AI to offer more precise and cost-effective solutions in healthcare.


 Citation

Please cite as:

Elvas LB, Almeida A, Ferreira JC

The Role of AI in Cardiovascular Event Monitoring and Early Detection: Scoping Literature Review

JMIR Med Inform 2025;13:e64349

DOI: 10.2196/64349

PMID: 40048151

PMCID: 11905924

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.